Try our corporate solution for free!
(212) 419-8294
vianny.gutierrez-cruz@statista.com

U.S. prices of Revlimid compared to prices in select countries 2020

Estimated U.S. prices of Revlimid compared to prices in Australia and Canada as of 2020*

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

March 2021

Region

Australia, Canada, United States

Survey time period

as of January 2020

Supplementary notes

* Prices are for a monthly supply of Revlimid Oral Capsule 10mg (28 capsules).
Estimated U.S. net prices reflect confidential rebates and other price concessions, information on such discounts was not publicly available for the comparison countries. Thus, the actual differences between U.S. prices and those of the other countries were likely larger than GAO estimates in this statistic.

Prices for selected comparison countries—Australia and Canada (Ontario)—were prices listed on their respective public formularies from January 2020 and were converted to U.S. dollars at the relevant monthly Federal Reserve rates.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Top pharmaceutical drugs"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.